Prognostic value of procalcitonin in Legionella pneumonia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 28, Issue 1, 2009, Pages 55-60

  Haeuptle, J ^a   Zaborsky, R ^a   Fiumefreddo, R ^a   Trampuz, A ^a   Steffen, I ^b   Frei, R ^a   Christ Crain, M ^a   Muller B ^a,c   Schuetz, P ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Kantonsspital Aarau ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; LEGIONELLA PNEUMOPHILA; LEUKOCYTE COUNT; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA SEVERITY INDEX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

AGED; C-REACTIVE PROTEIN; CALCITONIN; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SWITZERLAND;

EID: 58149149934     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0592-5     Document Type: Article

References (24)

1. B Muller S Harbarth D Stolz R Bingisser C Mueller J Leuppi 2007 Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia BMC Infect Dis 7 10
2. L Simon F Gauvin DK Amre P Saint-Louis J Lacroix 2004 Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis Clin Infect Dis 39 2 206 217
3. M Christ-Crain D Jaccard-Stolz R Bingisser MM Gencay PR Huber M Tamm 2004 Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial Lancet 363 9409 600 607
4. M Briel M Christ-Crain J Young P Schuetz P Huber P Periat 2005 Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners BMC Fam Pract 6 34
5. M Christ-Crain D Stolz R Bingisser C Muller D Miedinger PR Huber 2006 Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial Am J Respir Crit Care Med 174 1 84 93
6. D Stolz M Christ-Crain R Bingisser J Leuppi D Miedinger C Muller 2007 Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy Chest 131 1 9 19
7. JU Jensen L Heslet TH Jensen K Espersen P Steffensen M Tvede 2006 Procalcitonin increase in early identification of critically ill patients at high risk of mortality Crit Care Med 34 10 2596 2602
8. S Harbarth K Holeckova C Froidevaux D Pittet B Ricou GE Grau 2001 Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis Am J Respir Crit Care Med 164 3 396 402
9. M Masia F Gutierrez S Padilla B Soldan C Mirete C Shum 2007 Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors Clin Microbiol Infect 13 2 153 161
10. M Korppi S Remes T Heiskanen-Kosma 2003 Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings Pediatr Pulmonol 35 1 56 61
11. L Franzin D Cabodi 2005 Legionella pneumonia and serum procalcitonin Curr Microbiol 50 1 43 46
12. C Prat J Dominguez F Andreo S Blanco A Pallares F Cuchillo 2006 Procalcitonin and neopterin correlation with aetiology and severity of pneumonia J Infect 52 3 169 177
13. JE Stout VL Yu 1997 Legionellosis N Engl J Med 337 10 682 687
14. WS Lim MM van der Eerden R Laing WG Boersma N Karalus GI Town 2003 Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 5 377 382
15. MJ Fine TE Auble DM Yealy BH Hanusa LA Weissfeld DE Singer 1997 A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 4 243 250
16. AM Neill IR Martin R Weir R Anderson A Chereshsky MJ Epton 1996 Community acquired pneumonia: aetiology and usefulness of severity criteria on admission Thorax 51 10 1010 1016
17. M Woodhead F Blasi S Ewig G Huchon M Leven A Ortqvist 2005 Guidelines for the management of adult lower respiratory tract infections Eur Respir J 26 6 1138 1180
18. JA Dominguez N Gali P Pedroso A Fargas E Padilla JM Manterola 1998 Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples J Clin Microbiol 36 9 2718 2722
19. TC Lee RM Vickers VL Yu MM Wagener 1993 Growth of 28 Legionella species on selective culture media: a comparative study J Clin Microbiol 31 10 2764 2768
20. P Schuetz M Christ-Crain M Wolbers U Schild R Thomann C Falconnier 2007 Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial BMC Health Serv Res 7 102
21. P Schuetz M Christ-Crain B Muller 2007 Biomarkers to improve diagnostic and prognostic accuracy in systemic infections Curr Opin Crit Care 13 5 578 585
22. ES Nylen B Muller KL Becker RH Snyder 2003 The future diagnostic role of procalcitonin levels: the need for improved sensitivity Clin Infect Dis 36 823 824
23. BM Tang GD Eslick JC Craig AS McLean 2007 Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis Lancet Infect Dis 7 3 210 217
24. B Muller M Christ-Crain P Schuetz 2007 Meta-analysis of procalcitonin for sepsis detection Lancet Infect Dis 7 8 498 499